Response by Hasific et al to Letter Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".

HomeCirculationVol. 148, No. 16Response by Hasific et al to Letter Regarding Article, “Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial” No AccessLetterRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessFull TextResponse by Hasific et al to Letter Regarding Article, “Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial” Selma Hasific, Lars Melholt Rasmussen, Jordi S. Dahl and Axel C.P. Diederichsen Selma HasificSelma Hasific https://orcid.org/0000-0001-7654-8492 Department of Cardiology (S.H., J.S.D., A.C.P.D.), Odense University Hospital, Denmark. Search for more papers by this author , Lars Melholt RasmussenLars Melholt Rasmussen https://orcid.org/0000-0001-5795-4794 Department of Clinical Biochemistry, Center for Individualized Medicine in Arterial Diseases (L.M.R.), Odense University Hospital, Denmark. Search for more papers by this author , Jordi S. DahlJordi S. Dahl Department of Cardiology (S.H., J.S.D., A.C.P.D.), Odense University Hospital, Denmark. Search for more papers by this author and Axel C.P. DiederichsenAxel C.P. Diederichsen https://orcid.org/0000-0002-1285-4826 Department of Cardiology (S.H., J.S.D., A.C.P.D.), Odense University Hospital, Denmark. Search for more papers by this author Originally published16 Oct 2023https://doi.org/10.1161/CIRCULATIONAHA.123.066271Circulation. 2023;148:1269–1270"Response by Hasific et al to Letter Regarding Article, “Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial”." Circulation, 148(16), pp. 1269–1270FootnotesCirculation is available at www.ahajournals.org/journal/circREFERENCES1. Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, Peeters F, Floege J, Keszei A, Marx N, et al. Slower progress of aortic valve calcification with vitamin K supplementation: results from a prospective interventional proof-of-concept atudy.Circulation. 2017; 135:2081–2083. doi: 10.1161/CIRCULATIONAHA.116.027011LinkGoogle Scholar2. Diederichsen ACP, Lindholt JS, Möller S, Øvrehus KA, Auscher S, Lambrechtsen J, Hosbond SE, Alan DH, Urbonaviciene G, Becker SW, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial.Circulation. 2022; 145:1387–1397. doi: 10.1161/CIRCULATIONAHA.121.057008LinkGoogle Scholar3. Griffin TP, Islam MN, Wall D, Ferguson J, Griffin DG, Griffin MD, O'Shea PM. Plasma dephosphorylated-uncarboxylated matrix Gla-protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential.Sci Rep. 2019; 9:18452. doi: 10.1038/s41598-019-54762-2CrossrefMedlineGoogle Scholar4. Hasific S, Øvrehus KA, Lindholt JS, et al. Effects of vitamin K2 and D supplementation on coronary artery disease in men: a RCT.JACC Adv. In Press.Google Scholar5. Hasific S, Øvrehus KA, Hosbond S, Lambrechtsen J, Kumarathurai P, Mejldal A, Ravn EJ, Rasmussen LM, Gerke O, Mickley H, et al. Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial.BMJ Open. 2023; 13:e073233. doi: 10.1136/bmjopen-2023-073233CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails October 17, 2023Vol 148, Issue 16 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.066271PMID: 37844144 Originally publishedOctober 16, 2023 PDF download Advertisement SubjectsValvular Heart Disease